Life Sciences Company to Launch Clinical Trial Using Crowdsourcing And Telemonitoring

Transparency Life Sciences, LLC (TLS), the world’s first clinical-stage drug development company based on open innovation, today announced that it is applying its expertise in crowdsourcing and digital telemonitoring technology to conduct a clinical trial of Auven Therapeutics’ Kiacta™  in patients with sarcoidosis, a rare systemic inflammatory disease.  Kiacta is an orally bioavailable small molecule that is…


Janssen Launches Neuroscience Catalyst Partnership with Academia

Janssen Inc. announced it has signed an agreement, facilitated by the Johnson & Johnson Innovation center in California, with the University of Toronto’s Centre for Collaborative Drug Research (CCDR) to form an open-source collaboration focused on novel therapeutic approaches to the treatment and management of mood disorders and Alzheimer’s disease.


Takeda moves oncology unit to Cambridge

The parent of Millennium Pharmaceuticals said Tuesday that its top executive in Cambridge is stepping down as part of a companywide reorganization. The new structure at Takeda Pharmaceutical Co. will include a strong focus on the cancer drug business at Cambridge-based Millennium, executives said. Millennium, located near Central Square, will become the home of the…

Copyright © 2014 WhiteCityNews, All rights reserved.